Analyzing...
Loading company...
Nothing flagged for monitoring
“Operates in Chemicals — Specialty & Commodity.”
₹719 Cr revenue.
COGS 63.6%, employees 6.3%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 2.9%▼ | 7.6% |
| ROCE | 6.3%▼ | 10.9% |
| Net Margin | 3.0%▼ | 5.1% |
| EBITDA Margin | 12.5%▲ | 12.1% |
| Debt To Equity | 0.32x▲ | 0.20x |
| Rev Growth 3yr | -14.4%▼ | 5.9% |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹725 Cr +0.8% | ₹719 Cr -0.6% | ₹723 Cr -31.3% | ₹1,052 Cr -8.8% | ₹1,153 Cr +52.8% | ₹755 Cr +11.8% | ₹675 Cr -2.5% | ₹692 Cr |
| Other Income | ₹4 Cr -58.5% | ₹9 Cr -7.1% | ₹9 Cr +15.8% | ₹8 Cr +8.3% | ₹7 Cr +24.9% | ₹6 Cr -72.2% | ₹21 Cr +144.9% | ₹9 Cr |
| Total Income | ₹728 Cr +0.1% | ₹727 Cr -0.7% | ₹732 Cr -30.9% | ₹1,060 Cr -8.7% | ₹1,161 Cr +52.6% | ₹761 Cr +9.3% | ₹696 Cr -0.7% | ₹701 Cr |
| COGS | ₹437 Cr -4.5% | ₹457 Cr -6.4% | ₹489 Cr -29.0% | ₹688 Cr -11.2% | ₹775 Cr +85.2% | ₹419 Cr +6.5% | ₹393 Cr -7.8% | ₹426 Cr |
| ₹701 Cr -3.3% | ₹724 Cr -1.6% | ₹736 Cr -20.6% | ₹928 Cr -5.8% | ₹985 Cr +71.0% | ₹576 Cr +12.1% | ₹514 Cr -3.1% | ₹530 Cr | |
| Profit Before Tax | ₹33 Cr | ₹3 Cr ↑ Recovery | (₹7 Cr) ↓ Decline | ₹137 Cr -22.1% | ₹176 Cr -4.7% | ₹185 Cr +1.1% | ₹183 Cr +6.8% | ₹171 Cr |
| Exceptional Items | ₹6 Cr | ₹0.00 Cr +100.0% | (₹3 Cr) ↓ Decline | ₹5 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| ₹10 Cr +79.5% | ₹6 Cr ↑ Recovery | (₹0.30 Cr) ↓ Decline | ₹35 Cr -28.3% | ₹48 Cr -10.6% | ₹54 Cr +27.7% | ₹42 Cr -15.4% | ₹50 Cr | |
| Net Profit | ₹22 Cr ↑ Recovery | (₹3 Cr) +59.2% | (₹8 Cr) ↓ Decline | ₹103 Cr -19.8% | ₹128 Cr -2.3% | ₹131 Cr -6.9% | ₹141 Cr +15.9% | ₹121 Cr |
| Profit (Owners) | ₹22 Cr ↑ Recovery | (₹4 Cr) +55.5% | (₹8 Cr) ↓ Decline | ₹88 Cr -22.2% | ₹113 Cr -1.1% | ₹115 Cr -17.3% | ₹139 Cr +4.0% | ₹133 Cr |
| Minority Interest | (₹0.01 Cr) ↓ Decline | ₹0.31 Cr ↑ Recovery | (₹0.01 Cr) ↓ Decline | ₹14 Cr -1.3% | ₹15 Cr -10.3% | ₹16 Cr +712.0% | ₹2 Cr ↑ Recovery | (₹0.02 Cr) |
| Other Comprehensive Income | (₹0.52 Cr) +45.9% | (₹0.95 Cr) ↓ Decline | ₹0.71 Cr +364.5% | ₹0.15 Cr -74.4% | ₹0.60 Cr -91.4% | ₹7 Cr | ₹0.00 Cr | ₹0.00 Cr |
| EPS | ₹7.75 | (₹1.33) | (₹3.04) | ₹32.45 | ₹41.72 | ₹42.19 | ₹57.01 | ₹113.60 |
| Diluted Shares | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
| Profit Or Loss Of Associates | (₹1 Cr) -95.7% | (₹0.76 Cr) +51.3% | (₹2 Cr) | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Valiant Organics Limited has informed the Exchange about Investor Presentation
Valiant Organics Limited has informed the Exchange about Copy of Newspaper Publication
Valiant Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Significant movement in price has been observed in Valiant Organics Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market...
Valiant Organics Limited has informed the Exchange about Investor Presentation
Valiant Organics Limited has informed the Exchange about Copy of Newspaper Publication
Valiant Organics Limited has informed the Exchange regarding the outcome of the Board meeting held on February 13, 2026.
Valiant Organics Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
The Exchange had sought clarification from Valiant Organics Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regula...
The Exchange has sought clarification from Valiant Organics Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regula...
Valiant Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Valiant Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Valiant Organics Limited has informed the Exchange regarding Allotment of 15000 Shares.
Valiant Organics Limited has informed the Exchange about Investor Presentation
Valiant Organics Limited has informed the Exchange about Copy of Newspaper Publication